General Information
Revision date
2011-01-04
Product name
xMAP Classification Control Microspheres , xMAP Reporter Microspheres , MagPlex Classification Control Microspheres (MCON1), FLEXMAP Classification Verifier Microspheres (F3DVER1) FLEXMAP e Classification Verifier Microspheres (F3DeVER1), FLEXMAP Reporter Verifier Microspheres (F3DVER2), xMAP Fluidics 1 (FLUID1) & xMAP Fluidics 2 (FLUID2)
1.2.1 Relevant identified uses
These are intended to be used in conjunction with the system calibrators to verify the optical calibration and optical integrity for the Luminex analyzer. This product is not intended to be used in place of the assay calibrators or assay controls that are required to verify the proper function of a given assay
Manufacturer Name
Luminex Corporation
Emergency telephone
1-877-785-2323
Icons in SDS
Company Information
company name
Luminex Corporation
e-mail address of the competent person responsible for the Safety Data Sheet
support@luminexcorp.com
Section 2
SECTION 2: Hazards identification
(29 CFR 1910.1200) Emergency overview Physical state : Liquid. [Clear liquid with colored precipitate and/or colored suspension.] Odor : None
Hazard statements
NOT EXPECTED TO PRODUCE SIGNIFICANT ADVERSE HEALTH EFFECTS WHEN THE RECOMMENDED INSTRUCTIONS FOR USE ARE FOLLOWED.
Precautionary statements
No known significant effects or critical hazards. Avoid prolonged contact with eyes, skin and clothing.
Potential Acute Health Effects
Inhalation : No known significant effects or critical hazards. Ingestion : No known significant effects or critical hazards. Skin : No known significant effects or critical hazards. Eyes : No known significant effects or critical hazards. Potential chronic health effects
Potential chronic health
No known significant effects or critical hazards. Carcinogenicity : No known significant effects or critical hazards. Mutagenicity : No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects : No known significant effects or critical hazards. Fertility effects : No known significant effects or critical hazards. Over-exposure signs/symptoms Inhalation : No specific data. Ingestion : No specific data. Skin : No specific data. Eyes : No specific data. Medical conditions aggravated by over- exposure : None known. See toxicological information (Section 11)
